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University of Maryland, College Park, MarylandABSTRACT Mitochondrial outer membrane permeabilization (MOMP) is a complex multistep process. Studies of MOMP
in vivo are limited by the stochastic variability of MOMP between cells and rapid completion of IMS protein release within single
cells. In vitro models have provided useful insights into MOMP. We have investigated the dynamics of Bax-mediated MOMP in
isolated mitochondria using ionic strength as a tool to control the rate of MOMP. We find that Bax can induce both transient per-
meabilization, detected by protein release, and more substantial long-lasting permeabilization, measured by the rate of oxidation
of added cytochrome c. We found that higher ionic strength causes Bax to form small channels quickly but the expansion of
these early channels is impeded. This inhibitory effect of ionic strength is independent of tBid. Channels formed under low ionic
strength are not destabilized by raising the ionic strength. Increase in ionic strength also increases the ability of Bcl-xL to inhibit
Bax-mediated MOMP. Ionic strength does not affect Bax insertion into mitochondria. Thus, ionic strength influences the
assembly of Bax molecules already in membrane into channels. Ionic strength can be used as an effective biophysical tool
to study Bax-mediated channel formation.INTRODUCTIONApoptosis is a form of programmed cell death that is crucial
to the elimination of damaged or unwanted cells. Its proper
execution is vital for appropriate development. A key event
in the apoptotic pathway is increased permeability of the
mitochondrial outer membrane (MOM), which leads to
the release of intermembrane space (IMS) proteins. These
proteins trigger the activation of downstream caspases,
which carry out the repackaging of the cell into apoptotic
bodies. The rate-limiting increase in MOM permeabiliza-
tion (MOMP) leading to the release of IMS proteins is
well known to be modulated by Bcl-2 family of proteins
(1–3). The Bcl-2 proteins can be categorized broadly on
the basis of their mode of action into pro-apoptotic and
anti-apoptotic proteins. Pro-apoptotic BH1-3 proteins act
directly to enhance MOMP by forming protein-permeable
pores. BH3-only proteins increase MOMP indirectly by
activating BH1-3 proteins or inhibiting anti-apoptotic
Bcl-2 proteins (or both). Anti-apoptotic BH1-4 type proteins
inhibit the action of the pro-apoptotic proteins (4–6).
The control of MOMP by the Bcl-2 proteins has been
studied extensively. Bax, normally cytosolic, upon activa-
tion by the BH3 only protein, tBid, targets the MOM,
inserts, and forms oligomeric pores (7–10). Bcl-xL inhibits
MOMP by either out-competing Bax for tBid and/or inter-
acting directly with Bax to inhibit its insertion into the
MOM (10,11). The molecular roles of different domains
of Bax in membrane insertion are well known (12–16).
Some amino acids have also been identified that either
enhance or eliminate the pro-apoptotic function of Bax
(14–16) but the properties of the oligomeric channel such
as size, stoichiometry, and kinetics of channel assemblySubmitted March 29, 2012, and accepted for publication June 29, 2012.
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dynamics of Bax-induced permeabilization of the MOM
to proteins in isolated mitochondria using ionic strength as
a modulating tool.
Because MOMP is a rapid, irreversible, essentially all-
or-none process where most IMS proteins are released
almost simultaneously within a few minutes (17–20),
in vitro models have been very useful in studying the regu-
lation of MOMP by Bcl-2 family proteins (8,11,13,21,22).
We use ionic strength as a diagnostic tool to provide mech-
anistic insights into the dynamics of Bax mediated
permeabilization.MATERIALS AND METHODS
The sources of materials used, the procedure for isolating mitochondria
from rat liver, the details of the Western blotting, the enzymatic assays
for protein release and cytochrome c accessibility, and the purification
procedure for the recombinant Bcl-2 proteins are all described in the
Supporting Material.Preparation of mitochondrial samples
for cytochrome c oxidation and IMS protein
release assays
Isolated rat liver mitochondria were incubated in buffers of varying salt
concentrations with the total osmotic pressure kept constant at 300 mOs
by addition of the appropriate amount of mannitol. A combination of
Bcl-2 family proteins (Bax, tBid, and Bcl-xL) was added to this mitochon-
drial suspension as needed. Before each experiment, the mitochondria were
diluted to a protein concentration of 160 mg/mL in FH (300 mM mannitol,
0.1 mM EGTA, and 5 mM HEPES, pH 7.4) buffer. Because mitochondrial
function degrades once diluted, the mitochondria were used within 10 min
of dilution. In all experiments, 600 mL of this mitochondrial dilution was
added to 400 mL of isoosmotic buffer (with either 25.1 mM KCl or
150 mM KCl) premixed with appropriate amounts of Bcl-2 family proteins
to achieve a final mitochondrial concentration of 96 mg/mL (and final [KCl]
of either 10 mM or 60 mM, respectively).http://dx.doi.org/10.1016/j.bpj.2012.06.047
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the [KCl]. The same methodology was followed when NaCl or potassium
lactobionate was tested. For 90 mM buffer, the mitochondrial stock was
diluted 50–100 fold in 150 mM KCl buffer to a protein concentration of
160 mg/mL. A quantity of 600 mL of this suspension was then diluted
with 400 mL of FH buffer containing the Bcl-2 family proteins to achieve
a final ionic strength of 90 mM. Except for time-course experiments, the
mitochondria were preincubated at 30C with the Bcl-2 family proteins
for 30 min. For all experiments using Bcl-xL, the Bcl-2 proteins were incu-
bated together for 10 min before the addition of mitochondria. Once the
incubation period was over, 100 mL of the mitochondrial suspension was
used for the cytochrome c accessibility assay, while the rest was centrifuged
and the supernatant used for adenylate kinase and sulfite oxidase assays. In
corresponding experiments, 50 mL of cyclosporin A (dissolved in dimethyl
sulfoxide to a stock concentration of 1 mg/mL) was added to 1 mL of mito-
chondrial suspension to a final concentration of 50 mM just before the
preincubation process.Normalization of data
Normalization of data was performed for two reasons:
1. The activity varied from one mitochondrial preparation to another.
2. The activity of some enzymes was sensitive to ionic strength.
The latter was especially important because the relevant parameters
sought were the degree of permeabilization of the outer membrane and
the fractional release of a particular protein. By normalizing, the results
obtained at different ionic strengths could be compared directly. Normali-
zation involved subtracting the activity of untreated mitochondria (control)
from the experimental value and dividing the difference by the maximal
activity after hypotonic shock (control subtracted) measured under the
same conditions (e.g., the same ionic strength).Statistics
The results are reported as mean5 SE of at least three independent exper-
iments. Significance was determined by Student’s t-test. The single asterisk
(*), double asterisk (**), and triple asterisk (***) symbols indicate signif-
icance with P values <0.05, <0.01, and <0.001, respectively.
N/S indicates P values >0.05 and thus judged to be not significant.FIGURE 1 Increase in ionic strength inhibits real-time permeabilization
by Bax without inhibiting IMS protein release. (A) Mitochondrial suspen-
sion was treated with 17 nM Bax and 120 nM tBid at either 10 mM
or 90 mM KCl buffer and rates of cytochrome c oxidation (black bar)
and AK release (gray bar) were measured. The asterisk (*) refers to the
statistically significant difference between the black bars. (B) The measured
rates of cytochrome c oxidation by mitochondria exposed to tBid/Bax at
the indicated KCl concentrations. The results are means 5 SE of three
experiments.RESULTS
Increase in ionic strength decreases real-time
MOMP but the extent of IMS protein release
increases
In isolated mitochondria, MOMP can be measured in two
ways:
The first method is one whereby release of IMS proteins
can be measured. This provides information on the
minimum size of the MOMP pore as well as the fraction
of the population of mitochondria that have been permeabi-
lized, but it does not define the status of the pore at any
given time.
The second method records the real-time flux of cyto-
chrome c across the outer membrane by measuring the
rate of oxidation of exogenously added cytochrome c.
MOM is impermeable to cytochrome c. However, once the
mitochondria are permeabilized with Bax, cytochrome c
crosses the MOM, accesses the cytochrome oxidaseBiophysical Journal 103(3) 483–491complex in the inner membrane, and becomes oxidized.
The rate of oxidation is directly proportional to the extent
of permeabilization, i.e., the size of the MOMP pore and
the number of pores in the mitochondrial population.
Both methods were used to observe the ability of Bax to
permeabilize the outer membrane at different KCl concen-
trations. Protein release from the IMS was monitored by
measuring the release of adenylate kinase (AK), 24 kDa.
Real-time permeabilization was measured by measuring
the rate of oxidation of exogenously added cytochrome c.
Neither Bax alone (up to 50 nM) nor tBid alone (up to
120 nM) resulted in any significant MOMP by either assay
method (see Fig. S2, A and B, in the Supporting Material).
However, when mitochondria were incubated with Bax
and tBid at either low salt (10 mM KCl) or high salt
(90 mM KCl) buffer, permeabilization was achieved
(Fig. 1 A and Fig. S2, A and B). After treatment, a fraction
FIGURE 2 Bax permeability induced at lower ionic strength was not
reversed by raising ionic strength. Mitochondrial suspensions were treated
with 8 nM Bax and 120 nM tBid for 30 min at 30C in either 10 mM or
90 mMKCl buffer. At the end of 30 min, the rate of cytochrome c oxidation
by these mitochondria was determined. Simultaneously, the mitochondrial
suspension incubated in 10 mM KCl buffer was centrifuged and mitochon-
drial pellet resuspended in 90 mM KCl buffer to raise the ionic strength.
This suspension was incubated for 30 min at 30C, and at the end of the
incubation, the rate of cytochrome c oxidation was measured. To correct
for any loss of mitochondria during centrifugation, control and lysed
samples with equivalent amount of mitochondria were also treated in an
identical manner and the pellet resuspended in 90 mM KCl buffer (control
without Bax or tBid) or H2O (lysed) and rates measured. The results are
means5 SE of three experiments.
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chrome c oxidation; the remaining suspension was centri-
fuged and the supernatant was assayed for AK activity. At
the lower KCl concentration (10 mM), a substantial amount
of both AK release and real-time permeabilization was
observed.
However, at the higher KCl concentration (90 mM), the
release of AK was comparable to (e.g., in Fig. 1 A), or some-
times more than that at low salt, depending on the Bax
concentration, but the extent of real-time permeabilization
was always much lower (Fig. 1 A). The real-time permeabi-
lization decreased linearly with increase in [KCl]. (Fig. 1 B)
This behavior is not specific to KCl but rather an ionic
strength effect because substituting KCl with either NaCl
or potassium lactobionate resulted in a similar decline in
cytochrome c oxidation rate with increasing salt concentra-
tion during the Bax/tBid treatment (see Fig. S2 C). In these
experimental conditions, PTP did not influence MOMP, as
we found that CsA did not alter the rate of cytochrome c
oxidation or AK release by Bax and tBid at either ionic
strength (see Fig. S3).
It was reported that tBid causes remodeling of the inner
membrane and ionic strength could affect this process
(23). This remodeling might explain the different rates of
cytochrome c oxidation observed at different ionic strengths
if restricted diffusion of cytochrome c between the cristae is
rate-limiting in our system and changed by the remodeling.
To investigate whether the cristae folds limit the cytochrome
c oxidation rate, we compared the maximal rates of cyto-
chrome c oxidation after osmotic lysis where swelling
unfolds the cristae and MOM permeabilization with digi-
tonin where the cristae structures remain intact at doses
that do not permeabilize the inner membrane (23,24). Under
our conditions, 0.01% digitonin selectively permeabilized
the MOM without releasing the matrix enzyme, fumarase
(see Fig. S4 A). Whether mitochondria were treated with
digitonin or hypotonic shock, in the presence of 10- or
90-mM KCl buffer, the rates of cytochrome c oxidation
were not significantly different. In another set, mitochondria
were preincubated for 30 min with tBid to allow remodeling
of the inner membrane at either ionic strength and then
treated with digitonin and similar oxidation rates were
observed (see Fig. S4 B). Thus, any potential changes in
the inner membrane due to changes in the ionic strength
did not affect the rates of cytochrome c oxidation observed.
The permeability of the outer membrane seems to be the
rate-limiting factor in the oxidation of exogenous cyto-
chrome c by mitochondria.
The different results obtained with the two methods of
measurement of permeability (AK release and cytochrome c
oxidation) could be explained in three ways:
1. Change in the energetics. The higher ionic strength
makes the channels flicker, allowing release without
much permeabilization.2. Transient permeabilization. At the higher ionic strength,
the channels form for some time and then close, resulting
in restoration of a protein impermeable outer membrane.
3. Kinetic delay. Bax channel formation beginswith small or
flickering channels butwith time, these become larger and
more stable. At high ionic strength, this process is slow.
Experiments were performed to distinguish among these
possibilities.MOMP induced at lower [KCl] is not reversed
by increasing the salt concentration
One interpretation of the ionic strength effect is that Bax
channels are in equilibrium between an open and a closed
state and the ionic strength influences the position of the
equilibrium. Perhaps the equilibrium favors the open state
at low ionic strength and the closed at high ionic strength.
To test this, Bax mediated MOMP was induced under low
ionic strength (10 mM KCl buffer) for 30 min by treating
mitochondria with Bax and tBid. Under these conditions,
a significant level of MOMP was achieved. The permeabi-
lized mitochondria were sedimented (14,000  g, 5 min)
and resuspended in higher ionic strength medium (90 mM
KCl buffer) and incubated for another 30 min.
We found that after switching from low salt to high salt
(90 mM), the MOMP did not decrease but remained at the
high value found at low salt (Fig. 2). This demonstrates
that the process is far from equilibrium. Thus, ionic strength
is not merely shifting a fast equilibrium between conductingBiophysical Journal 103(3) 483–491
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a highly permeable state, that state is not reversible. Thus,
the first option is not correct. A time course of growth of
real-time MOMP with Bax and tBid shows that the rate
of permeabilization is monotonic. There is no indication
of a transient permeabilization because at all times tested,
the real-time permeability remained low at higher ionic
strength. Thus, the second option is incorrect. However, it
is also clear that the permeabilization increases much faster
at low salt than at high salt (see Fig. S5). Thus, the differ-
ence between the two methods is partly explained by
a difference in kinetics.FIGURE 3 Bax channels expand in size with time but this expansion is
slower at higher ionic strength. Mitochondrial suspensions were incubated
in 10 mM KCl buffer (A, C, E, and G) or 90 mM KCl buffer (B, D, F, and
H) with 120 nM tBid and either 8 nM Bax (A and B) or 17 nM Bax (C and
D) or 34 nM Bax (E and F) or 50 nM Bax (G and H) for various time points
at 30C. Then the mitochondria were centrifuged and the supernatants were
assayed for either AK release (solid lines) or SOX release (dashed lines).
Percentagevalues next toSOXdata indicate%ofAKpermeablemitochondria
that havebeenpermeabilized toSOX.Note that in somecases the error bars are
smaller than the data point. The results are means5 SE of three experiments.At high ionic strength, Bax forms smaller
channels more rapidly
To better understand the kinetics of Bax channel formation,
the Bax-induced release of AK (24 kDa) and that of a larger
protein sulfite oxidase (SOX, 120 kDa) were measured as a
function of time and ionic strength using different Bax
concentrations (Fig. 3). At all Bax concentrations tested,
the rate of release of AK was faster at 90 mM than at
10 mM KCl. At the smallest Bax concentration tested
(8 nM), the release of SOX lagged behind the release of
AK at both salt concentrations (Fig. 3, A and B). Because
the flux of proteins across the membrane through the Bax
pore is not rate-limiting (see Discussion), the increase in
the amount of release corresponds to the formation of chan-
nels in more mitochondria. The kinetic delay between the
release of AK and SOX suggests that the channels grow in
size with time. At a higher Bax concentration (17 nM),
the rates of release of AK and SOX were identical for
10 mM KCl but at 90 mM, the release of AK was faster
than release of SOX (Fig. 3, C and D).
It must be noted again that the rate of AK release was
higher with 90 mM KCl than with 10 mM KCl. At 34 nM,
with 90 mM KCl, the amount of release of AK saturated at
30 min, indicating that essentially all the mitochondria
were permeabilized but only about half of the channels
were large enough to allow to flux of SOX. The release of
SOX increased with time and by 60 min, 90% of the AK
permeable mitochondria had channels large enough to
release SOX, clearly indicating slow channel growth. In
contrast, at 10 mM KCl, the release of AK and SOX
increased synchronously (Fig. 4, E and F), indicating slower
channel formation but fast growth to a large size capable of
releasing both proteins at the same time. Clearly, both the
initial permeabilization of mitochondria, as indicated by
the AK release, and the growth of channels, as indicated by
the % of permeabilized mitochondria that released SOX,
are augmented by increasing the Bax concentration. The
extent of SOX release did not change very much comparing
low and high salt, but that can be explained by the conflicting
effects of ionic strength: augmenting the formation of new
channels and inhibiting their rate of growth.Biophysical Journal 103(3) 483–491tBid does not alter the sensitivity of Bax-induced
MOMP to ionic strength
tBid is necessary for Bax to permeabilize the MOM. Thus,
we hypothesized that the interaction between tBid and Bax
may be sensitive to ionic strength, i.e., changing the tBid
concentration could change the sensitivity of Bax-induced
MOMP to ionic strength. Increasing the level of tBid might
FIGURE 4 Ionic strength effect on Bax channel dynamics is not medi-
ated by tBid. Mitochondrial suspensions were incubated in 10 mM KCl
buffer (solid line) or 90 mM KCl buffer (dashed line) with 34 nM Bax
and varying concentrations of tBid (24, 60, and 120 nM) for 30 min at
30C. Then, the real-time permeability was determined by measuring the
cytochrome c oxidation rate. There was no significant difference in cyto-
chrome c oxidation rates between any treatments at 90 mM KCl buffer.
The results are mean5 SE of three experiments.
FIGURE 5 Increase in ionic strength increases the efficiency of Bcl-xL
in inhibiting Bax-mediated MOMP. Mitochondrial suspensions were incu-
bated with 17 nM Bax, 120 nM tBid, and varying concentrations of purified
Bcl-xL (48, 120, 160, and 240 nM) at either 10 mM KCl buffer (solid line)
or 90 mMKCl buffer (dashed line) for 30 min at 30C. Then, the mitochon-
dria were centrifuged and supernatant assayed for AK release. The results
are means5 SE of three experiments.
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MOMP induced by Bax was measured in either 10 mM or
90 mM KCl buffer at three different tBid concentrations
(Fig. 4). The permeabilization did not change over a wide
concentration range of tBid at either ionic strength. This is
consistent with a catalytic function of tBid in initiating
Bax-mediated MOMP (25,26), but not in the growth
process. Thus, the influence of ionic strength on MOMP is
not due to an effect on tBid.Ionic strength affects Bcl-xL-mediated inhibition
of MOMP by Bax-tBid
Bcl-xL inhibits MOMP by multiple processes. We tested
whether the inhibition of Bax-mediated MOMP by Bcl-xL
is also sensitive to ionic strength. We hypothesized that
because decreasing the ionic strength resulted in more stable
permeabilization (a pro-apoptotic effect), a higher ionic
strength will facilitate Bcl-xL-mediated MOMP inhibition.
Consistent with this hypothesis, for a given amount of
tBid and Bax, less Bcl-xL was needed to inhibit MOMP at
90 mM KCl than at 10 mM KCl (Fig. 5). Unlike what was
observed for the action of tBid on Bax, inhibition of
MOMP by Bcl-xL changed with the tBid concentration
(see Fig. S6). Presumably, tBid reduced the amount of
Bcl-xL available to interact with and inhibit Bax.Change in ionic strength has little effect on
membrane insertion of Bax
It is possible that ionic strength could interfere with the
extent of Bax insertion into the membrane, causing differ-ences in the degree of permeability. Our initial hypothesis
was that more Bax inserts into mitochondria at higher ionic
strength, causing more mitochondria to be permeabilized;
hence, greater release of AK. To test this hypothesis, mito-
chondria were incubated with Bax and tBid and the amount
of AK released was measured at 10, 20, and 30 min of incu-
bation. We found that, although there was an almost three-
fold difference in the amount of AK released at 10 min
between 10 and 90 mM KCl, the amount of Bax inserted
was about the same (Fig. 6, A and B). In our hands, Bax
insertion was essentially complete by 10 min. Although
there was no significant difference in the amount of Bax
inserted across the time points tested, AK release increased
with time (Fig. 6 B), indicating that new channel formation
in more mitochondria continued with time.
Thus, ionic strength affected the channel formation
process rather than Bax insertion. This is consistent with
the observation made with purified Bak whose insertion
into membranes is not affected by salt concentration (27).
To test whether ionic strength affected Bcl-xL-mediated
inhibition of Bax insertion into membranes, mitochondria
were incubated with Bax and tBid with or without Bcl-xL.
We found that Bcl-xL had little effect on Bax insertion,
although there was a complete inhibition of AK release
(see Fig. S7). Therefore, under these conditions, Bcl-xL
inhibits MOMP by interfering with Bax channel formation.DISCUSSION
Bax activation and subsequent MOMP occur in multiple
steps that are only partially understood. MOMP is a rapid
and irreversible process and very stochastic in cellBiophysical Journal 103(3) 483–491
FIGURE 6 Bax insertion into mitochondrial outer membranes is not
affected by ionic strength. (A) Mitochondrial suspensions (960 mg mito-
chondrial protein/mL) were treated with 50 nM Bax and 240 nM tBid for
increasing amounts of time (10, 20, and 30 min) in either 10 mM or
90 mM KCl buffer. Then the mitochondria were centrifuged and superna-
tant assayed for AK release. The pellets were subjected to carbonate treat-
ment and probed for Bax insertion by Western blot. The carbonate
treatment Western blots were performed as described in the Materials and
Methods in the Supporting Material. VDAC served as loading control.
(B) Extent of AK release at 10 (solid line) and 90 mM KCl buffer (dashed
line) for time points corresponding to those in A.
488 Ganesan et al.populations (17–20). Thus, in vitro models have been used
to gain insights into this process. Bax is a cytosolic mono-
meric protein in normal cells, but upon apoptotic induction,
translocates to MOM, forms homo-oligomers and hetero-
oligomers with Bak and some other proteins (28–34), and
induces MOMP.
We show that increasing the ionic strength influences the
size of the Bax channels, consequently leading to smaller
channels.
In summary, our results are consistent with the following
conclusions:
1. Bax insertion into MOM is fast and is followed by
channel formation and then a slow growth in channel size.
2. The rate of formation of channels, as measured by the
kinetics of AK release at different salt concentrations,
is faster at higher salt concentration.
3. The rate of expansion of the size of the initial channels is
faster at the lower salt concentration, as measured by
comparing the kinetics of release of AK and SOX and
the time course of growth of real-time MOMP.
4. This effect of salt concentration on the rate of growth of
Bax channels explains the differences in the extent of
real-time MOMP seen with the cytochrome c oxidation
assay at different salt concentrations.Biophysical Journal 103(3) 483–4915. Increase in ionic strength also makes Bax-mediated
MOMP more sensitive to inhibition by Bcl-xL.
6. Ionic strength does not affect the insertion of Bax into
membranes, suggesting that subsequent steps in channel
formation are impeded by an elevated ionic strength.
Key to gaining insight into the dynamics of Bax channel
formation and the influence of ionic strength on this
dynamics is the measurement of outer membrane permeabi-
lization in two ways: 1), IMS protein release, and 2), the rate
of cytochrome c oxidation. Because of the small volume of
the intermembrane space and the long timescale of our
experiments, once a channel is formed in one mitochondrion
that is large enough to allow the translocation of a particular
protein, e.g., AK, all the AK will be released from that mito-
chondrion within a few milliseconds. Thus, the time-depen-
dent release of AK or SOX from a population of
mitochondria does not measure the rate of release from
each individual mitochondrion, but the rate of permeabiliza-
tion of each of the mitochondria in the population. There-
fore, partial release of AK signifies that only a portion of
the mitochondrial population has Bax channels large
enough to allow AK release. A difference in the extent of
release of AK and SOX in the population means that some
mitochondria have channels that are too small to release
SOX but are large enough to release AK. It is important to
note that release of AK and SOX is independent of ionic
strength (35,36); hence, these proteins may be more suitable
for measuring MOMP than cytochrome c release. Cyto-
chrome c, being a charged protein, binds membranes, espe-
cially the inner membrane of mitochondria that is rich in
cardiolipin, and a separate dissociation step is necessary to
facilitate cytochrome c release apart from pore formation
(35,37). Thus, assessing permeabilization of the outer
membrane becomes more complicated if measuring cyto-
chrome c release.
A change in ionic strength is not a very specific tool, and
therefore other possible effects of ionic strength that may
influenceMOMPwere examined. Over a wide concentration
range of tBid, the sensitivity to ionic strength did not
change—suggesting that the interaction between tBid and
Bax is not affected by changes in ionic strength. tBid has
been reported to remodel cristae in a PTP-dependent manner
(23), releasing loosely bound IMS proteins from inner
membrane into the IMS. Given the catalytic rather than stoi-
chiometric nature of tBid in facilitating Bax-mediated
MOMP (25,26) and that Bax-mediated cytochrome c oxida-
tion rate did not changewith tBid at either ionic strength, this
is consistent with amodel inwhich the effect of ionic strength
is directly on the ability of Bax to form channels in theMOM
rather than on the structure of the inner membrane. The inner
membrane remodeling induced by tBid was inhibitable by
CsA (23) but, in our hands, the exogenous cytochrome c
oxidation induced by Bax-tBid at either ionic strength was
independent of the presence of CsA. This is consistent with
Ionic Strength Affects Bax Channel Kinetics 489other reports (38–41) that foundMOMP induced by Bax and
tBid to be independent of PTP (see Fig. S2).
These observations strongly signify that the cytochrome c
oxidation rates observed after Bax-tBid treatment are
limited by MOM permeability rather than other effects on
the structure of inner membrane. Though we do not rule
out that changes are caused to the inner membrane by
tBid under our conditions, these changes do not affect the
interpretation of MOM permeability from the cytochrome
c oxidation assay. Thus, the rate of oxidation of exoge-
nously-added reduced cytochrome c measures the actual
permeability of the MOM at any time (real-time permeabi-
lization) and depends on the number of channels and the
size of channels present. However, it does not distinguish
between many small channels spread out among many mito-
chondria or a few large channels in just a few mitochondria.
Thus, each type of assay measures different properties of the
permeabilizing pore. By combining the results obtained
from the three assays (AK release, SOX release, and cyto-
chrome c oxidation) one obtains a good picture of the nature
of the permeabilization of the MOM.
At low ionic strength, there is general congruency
between the permeability measurements (cytochrome c
oxidation rates) and the amount of protein release but,
nevertheless, the % permeabilization is quite a bit smaller
(half in Fig. 1 A) than the % AK release. Fig. 3 shows that
at this level of Bax, the release of AK and SOX are the
same. Thus, the Bax channels are large enough to release
SOX, but not large enough to keep from limiting the rate
of cytochrome c oxidation. To allow SOX release, the Bax
pore must be >3.3 nm in radius. Simple calculations show
that such a pore would limit cytochrome c translocation
rates under the conditions of our experiments. Electron
microscopy of Bax channels formed in liposomes show
that Bax channel can reach much larger sizes (42,43), and
under those conditions they would certainly not be rate-
limiting. Thus, channel growth requires time both at low
and high ionic strength, and this is also seen at 8 nM Bax
(Fig. 3) when comparing the release of AK and SOX. The
quicker release of AK at higher salt suggests that the initial
pore formation by Bax is faster at higher ionic strength.
However, the release of SOX showed a greater time lag
for release at higher ionic strength. This indicates that the
Bax channels start out small and grow in size and the expan-
sion is delayed by increasing ionic strength. Thus, the Bax
channel-forming process seems to consist of two stages: 1),
initial formation of channels capable of releasing AK (stim-
ulated by high ionic strength), and 2), growth of channels
(inhibited by high ionic strength). The small channels limit
the rate of cytochrome c oxidation, resulting in low real-
time permeabilization and thus low oxidation rates.
Kluck et al. (44) first observed a dichotomy between
extent of IMS protein release and real-time permeabilization
in mitochondria treated with Bax or tBid. The apparent
paradoxical finding that the extent of MOMP depended onthe technique used to make the measurement is resolved
by the experiments reported in this article. MOMP measure-
ment is complicated by the growth in Bax channel size and
the marker of permeabilization is also influenced by channel
size. We find that the real-time permeability induced by Bax
and tBid increases with time and is influenced by ionic
strength. Larger channels formed at lower ionic strength
allow greater flux of exogenous cytochrome c, causing its
faster rate of oxidation. A high rate of cytochrome c oxida-
tion does not imply unphysiologically high channel sizes as
we found that such permeabilities happened when release of
AK or SOX was submaximal. In cells, release of most IMS
proteins is rapid and complete (17). It is an all-or-none event
(17–20). Thus, one can conclude that large channels are
present in vivo, and these have been observed in reconsti-
tuted systems (42,43).
We found that Bcl-xL was essentially ineffective at pre-
venting Bax insertion even at concentrations of Bcl-2
proteins when MOMP was completely inhibited. Thus, in
the experimental conditions and concentrations of Bcl-2
proteins we used, Bcl-xL may be acting at the level of
Bax channel formation. Such an experimental setting
provides a platform to study the mechanics of Bax channel
assembly downstream of Bax insertion into membranes.CONCLUSION
In summary, we have identified that decreasing ionic strength
results in the formation of large channels that allow high flux
rates of cytochrome c and synchronously release both small
and large proteins. High ionic strength favors the initial
formation of small channels and these develop more slowly
into the larger structures that were observed much sooner
at low ionic strength. Higher ionic strength also increases
the sensitivity of Bax-mediated MOMP to inhibition by
Bcl-xL. Ionic strength can be used as a diagnostic tool to
dissect the different steps in Bax-mediated MOMP.SUPPORTING MATERIAL
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